Kris Kristofferson fans remember his moving show of support for Sinead O’Connor
Kristofferson memorably comforted the younger artist after she was booed and heckled following her protest on ‘Saturday Night ...
Hurricane Helene flooding poses multiple health risks. Here's what to know.
Hurricane Helene's​ massive rains and flooding is a major health and safety risk for residents exposed to potential ...
Zacks.com on MSN4h
Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
Sanofi SNY and partner Regeneron REGN announced that the FDA has approved their blockbuster drug, Dupixent, for its sixth ...
FDA Approves Dupixent Injections For People Struggling With COPD Symptoms
The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...
pulmonologyadvisor6h
Dyspnea Impact Worse in People With PRISm vs Undiagnosed Asthma or COPD
In adults with undiagnosed respiratory symptoms, dyspnea impact was worse in those with PRISm vs undiagnosed asthma or COPD.
Monthly Prescribing Reference7h
Dupixent Approved as Add-On Maintenance Therapy in COPD
The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.
Study proposes new heart failure treatment targeting abnormal hormone activity
Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ...
emjreviews.com8h
Sanofi and Regeneron’s allergy drug approved as first biologic for COPD
Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the ...
copdnewstoday8h
FDA approves Dupixent for adults with poorly controlled COPD
The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of ...
Too Old to Operate9h
PSI Outperforms CURB-65 and qSOFA in Predicting Mortality and Costs for Patients with COPD and Pneumonia
The following is a summary of “Comparative Effectiveness of qSOFA, CURB-65, and PSI in Predicting Pneumonia Hospitalization ...
Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024
Ohtuvayre (ensifentrine) is a first-in-class selective dual inhibitor of the enzymes phosphodiesterase three and phosphodiesterase 4 (“PDE3 and PDE4”) that combines bronchodilator and non-steroidal ...